Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
Researcher
- Ali Passian
- Brian Sanders
- Bruce Moyer
- Claire Marvinney
- Debjani Pal
- Gerald Tuskan
- Harper Jordan
- Ilenne Del Valle Kessra
- Isaiah Dishner
- Jeff Foster
- Jeffrey Einkauf
- Jennifer M Pyles
- Jerry Parks
- Joel Asiamah
- Joel Dawson
- John F Cahill
- Josh Michener
- Kuntal De
- Laetitia H Delmau
- Liangyu Qian
- Luke Sadergaski
- Nance Ericson
- Paul Abraham
- Srikanth Yoginath
- Varisara Tansakul
- Vilmos Kertesz
- Xiaohan Yang
- Yang Liu

Enzymes for synthesis of sequenced oligoamide triads and tetrads that can be polymerized into sequenced copolyamides.
Contact
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

Technologies directed quantum spectroscopy and imaging with Raman and surface-enhanced Raman scattering are described.

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).